TY - JOUR
T1 - Comparison of Sagittal FSE T2, STIR, and T1-weighted phase-sensitive inversion recovery in the detection of spinal cord lesions in MS at 3T
AU - Alcaide-Leon, Paula
AU - Pauranik, A.
AU - Alshafai, L.
AU - Rawal, S.
AU - Oh, J.
AU - Montanera, W.
AU - Leung, G.
AU - Bharatha, A.
N1 - Funding Information:
This study was partially funded by Novartis in the form of an educational grant to support the fellowship training position for the first author (P.A.-L.). (Money paid to the institution.) Paula Alcaide-Leon - RELATED: Grant: Novartis. Sapna Rawal - UNRELATED: Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: Association of University Radiologists - GE Radiology Research Academic Fellowship Award, Comments: I am a recipient of the Association of University Radiologists - GE Radiology Research Academic Award for 2015, and the sponsoring body paid for my travel expenses to the Association of University Radiologists meeting in April 2015. Jiwon Oh - UNRELATED: Consultancy: Biogen-Idec, Novartis, Teva, Genzyme, EMD Serono, Roche; Grants/Grants Pending: Biogen-Idec, Genzyme, Multiple Sclerosis Society of Canada; Payment for Lectures (including service on Speakers Bureaus): EMD Serono, Novartis, Genzyme, Teva, Biogen-Idec; Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: Genzyme, EMD Serono. General Leung - UNRELATED: Grants/Grants Pending: University of Toronto, Comments: Internal funding was received for a project for carotid atherosclerosis imaging; Patents (planned, pending or issued): operation of wireless devices through the Faraday Cage, inhibition of intraplaque hemorrhage using drug therapy; Other: In-kind support was received from Siemens, Synaptive Medical, VisualSonics/Fujifilm. Aditya Bharatha - RELATED: Grant: Novartis, Comments: educational grant to support research fellow (first author, P.A.-L.); UNRELATED: Payment for Lectures (including service on Speakers Bureaus): EMD Serono, Novartis, Biogen, Comments: honoraria for educational lectures on MS. Money paid to the institution.
PY - 2016/5
Y1 - 2016/5
N2 - BACKGROUND AND PURPOSE: Determining the diagnostic accuracy of different MR sequences is essential to design MR imaging protocols. The purpose of the study was to compare 3T sagittal FSE T2, STIR, and T1-weighted phase-sensitive inversion recovery in the detection of spinal cord lesions in patients with suspected or definite MS. MATERIALS AND METHODS: We performed a retrospective analysis of 38 patients with suspected or definite MS. Involvement of the cervical and thoracic cord segments was recorded on sagittal FSE T2, STIR, and T1-weighted phase-sensitive inversion recovery sequences independently by 2 readers. A consensus criterion standard read was performed with all sequences available. Sensitivity, specificity, and interobserver agreement were calculated for each sequence. RESULTS: In the cervical cord, the sensitivity of T1-weighted phase-sensitive inversion recovery (96.2%) and STIR (89.6%) was significantly higher (P < .05) than that of FSE T2 (50.9%), but no significant difference was found between T1-weighted phase-sensitive inversion recovery and STIR. In the thoracic cord, sensitivity values were 93.8% for STIR, 71.9% for FSE T2, and 50.8% for T1-weighted phase-sensitive inversion recovery. Significant differences were found for all comparisons (P < .05). No differences were detected in specificity. Poor image quality and lower sensitivity of thoracic T1-weighted phase-sensitive inversion recovery compared with the other 2 sequences were associated with a thicker back fat pad. CONCLUSIONS: The use of an additional sagittal sequence other than FSE T2 significantly increases the detection of cervical and thoracic spinal cord lesions in patients with MS at 3T. In the cervical segment, both STIR and T1-weighted phase-sensitive inversion recovery offer high sensitivity and specificity, whereas in the thoracic spine, STIR performs better than T1-weighted phase-sensitive inversion recovery, particularly in patients with a thick dorsal fat pad.
AB - BACKGROUND AND PURPOSE: Determining the diagnostic accuracy of different MR sequences is essential to design MR imaging protocols. The purpose of the study was to compare 3T sagittal FSE T2, STIR, and T1-weighted phase-sensitive inversion recovery in the detection of spinal cord lesions in patients with suspected or definite MS. MATERIALS AND METHODS: We performed a retrospective analysis of 38 patients with suspected or definite MS. Involvement of the cervical and thoracic cord segments was recorded on sagittal FSE T2, STIR, and T1-weighted phase-sensitive inversion recovery sequences independently by 2 readers. A consensus criterion standard read was performed with all sequences available. Sensitivity, specificity, and interobserver agreement were calculated for each sequence. RESULTS: In the cervical cord, the sensitivity of T1-weighted phase-sensitive inversion recovery (96.2%) and STIR (89.6%) was significantly higher (P < .05) than that of FSE T2 (50.9%), but no significant difference was found between T1-weighted phase-sensitive inversion recovery and STIR. In the thoracic cord, sensitivity values were 93.8% for STIR, 71.9% for FSE T2, and 50.8% for T1-weighted phase-sensitive inversion recovery. Significant differences were found for all comparisons (P < .05). No differences were detected in specificity. Poor image quality and lower sensitivity of thoracic T1-weighted phase-sensitive inversion recovery compared with the other 2 sequences were associated with a thicker back fat pad. CONCLUSIONS: The use of an additional sagittal sequence other than FSE T2 significantly increases the detection of cervical and thoracic spinal cord lesions in patients with MS at 3T. In the cervical segment, both STIR and T1-weighted phase-sensitive inversion recovery offer high sensitivity and specificity, whereas in the thoracic spine, STIR performs better than T1-weighted phase-sensitive inversion recovery, particularly in patients with a thick dorsal fat pad.
UR - http://www.scopus.com/inward/record.url?scp=84969780593&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969780593&partnerID=8YFLogxK
U2 - 10.3174/ajnr.A4656
DO - 10.3174/ajnr.A4656
M3 - Article
C2 - 26797141
AN - SCOPUS:84969780593
SN - 0195-6108
VL - 37
SP - 970
EP - 975
JO - American Journal of Neuroradiology
JF - American Journal of Neuroradiology
IS - 5
ER -